PRESS RELEASE published on 03/17/2023 at 08:00, 3 years ago Biophytis annonce un changement de ratio pour son programme d'American Depositary Receipt ('ADR')
PRESS RELEASE published on 03/09/2023 at 08:00, 3 years ago Biophytis To Present Positive Results of Phase 2-3 COVA Study At ERS 2023 21st Lung Science Conference
PRESS RELEASE published on 03/09/2023 at 08:00, 3 years ago Biophytis présente les résultats positifs de Phase 2-3 COVA à la 21ème Conférence « Lung Science » - ERS 2023
PRESS RELEASE published on 03/02/2023 at 00:00, 3 years ago Biophytis annonce la signature d’un accord-cadre avec Intsel Chimos, laboratoire pharmaceutique qui exploitera Sarconeos (BIO101) en France pour le traitement des formes sévère de COVID-19
PRESS RELEASE published on 03/02/2023 at 00:00, 3 years ago Biophytis announces the signature of a master service agreement with Intsel Chimos, a pharmaceutical company that will operate Sarconeos (BIO101) in France for the treatment of severe forms of COVID-1
PRESS RELEASE published on 02/27/2023 at 08:00, 3 years ago Biophytis: Biophytis démarre le processus règlementaire de demande d’autorisation d’accès précoce en France auprès de la Haute Autorité de Santé (HAS) pour le traitement avec Sarconeos (BIO101) des fo
PRESS RELEASE published on 02/27/2023 at 08:00, 3 years ago Biophytis initiates the regulatory process for an early access authorization in France from the French National Authority for Health (HAS) for the treatment with Sarconeos (BIO101) of severe forms of
PRESS RELEASE published on 02/23/2023 at 08:00, 3 years 1 month ago : Biophytis To Host A Combined General Shareholder’s Meeting On March 30, 2023
PRESS RELEASE published on 02/23/2023 at 08:00, 3 years 1 month ago Biophytis annonce la convocation d’une assemblée générale mixte le 30 mars 2023
PRESS RELEASE published on 02/02/2023 at 08:00, 3 years 1 month ago Biophytis: Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19
Published on 03/23/2026 at 14:05, 1 hour 59 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 2 hours 4 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 2 hours 59 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 3 hours 32 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 3 hours 34 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 15:05, 58 minutes ago Heidrick & Struggles Launches Heidrick Immersive, an AI-Enhanced Platform for Observing Leadership in Motion
Published on 03/23/2026 at 14:41, 1 hour 22 minutes ago CEWE increases dividend for 17 consecutive years
Published on 03/23/2026 at 14:30, 1 hour 33 minutes ago Solvias Earns EcoVadis Bronze Medal, Ranking in Top 35% of Companies for Sustainability Performance
Published on 03/23/2026 at 14:30, 1 hour 33 minutes ago Belvilla Expands in Germany with Hambachtal Holiday Park in Oberhambach
Published on 03/23/2026 at 14:24, 1 hour 39 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 03/23/2026 at 08:10, 7 hours 54 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 21 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 21 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 21 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 21 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
